Hossein Torabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hossein Torabi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Feizkhah
Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
1 shared publication - Anoush Dehnadi Moghadam
Anesthesiology Research Center Guilan University of Medical Sciences Rasht Iran
1 shared publication - Habib Eslami Kenarsari
Guilan University of Medical Sciences, Razi Clinical Research Development Unit, Department of Biostatistics, Rasht, Iran
1 shared publication - Joseph Osuji
School of Nursing and Midwifery, Faculty of Health, Community, and Education, Mount Royal University, Calgary, Ab, Canada
1 shared publication - Kasra Shirini
Department of Surgery Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publication - Mohammad Javad Ghazanfari
Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- RetractedOpen Access
- 24 April 2023
- Published by Wiley in International Wound Journal
- Vol. 20 (8) , 3204-3211
RETRACTED: Acute burns during the COVID‐19 pandemic: A one‐year retrospective study of 611 patients at a referral burn centre in northern Iran
Patients with acute burns are more vulnerable to COVID‐19 because of physiologically weak immune systems. This study aimed to assess and compare individual characteristics, clinical features, and clinical outcomes of acute burn among COVID‐19 and non‐COVID‐19 patients. A retrospective study, with data collected from 611 acute burn patients with or without a COVID‐19 diagnosis referred to a burn centre in Iran. Data were collected from April 2020 to 2021. The mean age of acute burns patients with COVID‐19 was higher compared with acute burns patients with non‐COVID‐19 (47.82 vs. 32.59 years, P < .001). Acute burns occurred more frequently in COVID‐19 patients with comorbidities compared with non‐COVID‐19 patients (48.72% vs. 26.92%, P = .003). 58.97% of COVID‐19 patients and 55.42% of non‐COVID‐19 patients had grade II & III and II burns, respectively (P < .001). The mean total body surface area of the burn was higher in COVID‐19 patients compared with non‐COVID‐19 patients (32.69% vs. 16.22%, P < .001). Hospitalisation in the intensive care unit (ICU) was higher in COVID‐19 patients than in non‐COVID‐19 patients (76.92% vs. 15.73%, P < .001). Length of stay in hospital and ICU, the cost of hospitalisation, and waiting time for the operating room was higher in COVID‐19 patients compared with non‐COVID‐19 patients (15.30 vs. 3.88 days, P < .001; 9.61 vs. 0.75 days, P < .001; 30 430 628.717 vs. 10 219 192.44 rials, P = .011; 0.84 vs. 0.24 min, P < .001, respectively). Intubation and mortality in‐hospital were higher in COVID‐19 patients compared with non‐COVID‐19 patients (41.02% vs. 6.99%, P < .001; 35.90% vs. 6.12%, P < .001, respectively). Therefore, it is recommended that health managers and policymakers develop a care plan to provide high‐quality care to acute burns patients with COVID‐19, especially in low‐income countries.
- 24 April 2023
- Published by Wiley in International Wound Journal
- Vol. 20 (8) , 3204-3211
RetractedOpen AccessRETRACTED: Acute burns during the COVID‐19 pandemic: A one‐year retrospective study of 611 patients at a referral burn centre in northern Iran
Patients with acute burns are more vulnerable to COVID‐19 because of physiologically weak immune systems. This study aimed to assess and compare individual characteristics, clinical features, and clinical outcomes of acute burn among COVID‐19 and non‐COVID‐19 patients. A retrospective study, with data collected from 611 acute burn patients with or without a COVID‐19 diagnosis referred to a burn centre in Iran. Data were collected from April 2020 to 2021. The mean age of acute burns patients with COVID‐19 was higher compared with acute burns patients with non‐COVID‐19 (47.82 vs. 32.59 years, P < .001). Acute burns occurred more frequently in COVID‐19 patients with comorbidities compared with non‐COVID‐19 patients (48.72% vs. 26.92%, P = .003). 58.97% of COVID‐19 patients and 55.42% of non‐COVID‐19 patients had grade II & III and II burns, respectively (P < .001). The mean total body surface area of the burn was higher in COVID‐19 patients compared with non‐COVID‐19 patients (32.69% vs. 16.22%, P < .001). Hospitalisation in the intensive care unit (ICU) was higher in COVID‐19 patients than in non‐COVID‐19 patients (76.92% vs. 15.73%, P < .001). Length of stay in hospital and ICU, the cost of hospitalisation, and waiting time for the operating room was higher in COVID‐19 patients compared with non‐COVID‐19 patients (15.30 vs. 3.88 days, P < .001; 9.61 vs. 0.75 days, P < .001; 30 430 628.717 vs. 10 219 192.44 rials, P = .011; 0.84 vs. 0.24 min, P < .001, respectively). Intubation and mortality in‐hospital were higher in COVID‐19 patients compared with non‐COVID‐19 patients (41.02% vs. 6.99%, P < .001; 35.90% vs. 6.12%, P < .001, respectively). Therefore, it is recommended that health managers and policymakers develop a care plan to provide high‐quality care to acute burns patients with COVID‐19, especially in low‐income countries.
- Open Access
- 30 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20827
A Rare Simultaneous Occurrence of Splenic and Pelvic Cavity Hydatid Cyst
Hydatid cyst is a significant health-threatening problem that can affect almost all organs, especially the lungs and the liver, but the possibility of its occurrence in organs such as the spleen or pelvic cavity is rare. Thus, simultaneous hydatid cysts in the spleen and pelvic cavity are probably very rare. Nevertheless, since hydatid cysts in different areas can cause various symptoms, it should be considered a significant diagnosis. This article presents a case report of a 21-year-old woman presenting with right lower quadrant abdominal pain mimicking appendicitis but found to have simultaneous hydatid cysts in the spleen and the pelvic cavity.
- 30 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20827
Open AccessA Rare Simultaneous Occurrence of Splenic and Pelvic Cavity Hydatid Cyst
Hydatid cyst is a significant health-threatening problem that can affect almost all organs, especially the lungs and the liver, but the possibility of its occurrence in organs such as the spleen or pelvic cavity is rare. Thus, simultaneous hydatid cysts in the spleen and pelvic cavity are probably very rare. Nevertheless, since hydatid cysts in different areas can cause various symptoms, it should be considered a significant diagnosis. This article presents a case report of a 21-year-old woman presenting with right lower quadrant abdominal pain mimicking appendicitis but found to have simultaneous hydatid cysts in the spleen and the pelvic cavity.